Back to search
CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma trials you may qualify forThe goal of this clinical research study is to learn if SGN-35 (brentuximab vedotin) can help to control ALCL, LyP or MF in patients with at least 1 of the 3 sk…
This phase I/II trial studies the side effects and best dose of modified umbilical cord blood immune cells (natural killer \[NK\] cells) combined with the antib…